載入...
Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer
A cornerstone of preclinical cancer research has been the use of clonal cell lines. However, this resource has underperformed in its ability to effectively identify novel therapeutics and evaluate the heterogeneity in a patient's tumor. The patient-derived xenograft (PDX) model retains the hete...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4226719/ https://ncbi.nlm.nih.gov/pubmed/25209969 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|